Co-primary endpoint analysis of HCRN GU 16-257: Phase 2 trial of gemcitabine, cisplatin, plus nivolumab with selective bladder sparing in patients with muscle-invasive bladder cancer (MIBC). This is ...

Stinchcombe, MD. The promising data from the phase I trial led to initiation of the phase II HERTHENA-Lung01 trial of HER3-DXd once every 3 weeks in patients with EGFR-mutated NSCLC who had previously ...

A non-opioid drug for pain developed by UK biotech Levicept, with a new mechanism of action, has shown it can reduce pain associated with osteoarthritis in a phase 2 trial. Neurotrophin-3 (NT-3 ...

See what moon phase it is tonight and find out when you can see the rest of the moon phases for 2025. Today, June 1, 2025, the moon is 5 days old and is in the Waxing Crescent phase of its lunar ...

After 24 weeks, those proportions reached 74.1% and 64.9% respectively, with the tolerability profile of the drug consistent with the phase 2 FRONTIER 1 and 2 studies reported last year.